NCT04484701View on ClinicalTrials.gov

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

1,574

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2028

Conditions

Prostatic NeoplasmProstatic Cancer

Interventions

DRUG

68Ga-PSMA-11

PET/CT scan with radiotracer 68Ga-PSMA-11

Trial Locations (1)

V5Z 4E6

BC Cancer, Vancouver

All Listed Sponsors

lead

British Columbia Cancer Agency

OTHER